In a first-of-its-kind study, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) report that even lead levels below the EPA's threshold in household water may adversely affect individuals with chronic kidney ...
May 30, 2024
1
2
The research group of Professor Riitta Lahesmaa have discovered a novel modulator for human regulatory T cells. This novel regulator can strengthen or dampen immune response and provides a new basis for therapeutic approaches ...
May 30, 2024
0
1
Cerebellar ataxia is a neurological disorder of the cerebellum. This important area at the back of the brain acts as a conductor, so to speak, coordinating our movements and keeping us in balance.
May 30, 2024
0
1
Healthy T cells are the foundation of a balanced immune system. They can spring into action to fight off infections or cancer, but keep from becoming so activated that they hurt the very cells they're meant to protect, as ...
May 29, 2024
0
24
Individuals living with sickle cell disease (SCD) who experience a delay of more than six months in transitioning from pediatric to adult care are twice as likely to be hospitalized compared to those who transition in less ...
May 29, 2024
0
9
University of Saskatchewan (USask) research, which has been published in Communications Biology, highlights the discovery of the lipid-lowering effects of nesfatin-1-like peptide (NLP). This newly identified peptide—or ...
May 28, 2024
0
8
Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer's disease research by identifying a novel way to potentially slow down or even halt disease progression. The study, ...
May 27, 2024
0
26
The stress of heart failure is remembered by the body and appears to lead to recurrent failure, along with other related health issues, according to new research. Researchers have found that heart failure leaves a "stress ...
May 24, 2024
0
56
A new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such as schizophrenia and Alzheimer's disease.
May 23, 2024
0
13
Scientists from the Berlin Institute of Health at Charité (BIH) and Open Targets together with colleagues from the University of Cambridge, and Addenbrooke's Hospital in Cambridge, U.K., uncovered mechanisms driving regeneration ...
May 23, 2024
0
36
